Cognition Therapeutics (CGTX) Shares Issued (2021 - 2026)
Cognition Therapeutics (CGTX) reported Shares Issued of $44000.0 for Q1 2026, down 96.99% year-over-year from $1.5 million in Q1 2025, and up 633.33% on a QoQ basis from $6000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 6 years of Shares Issued data on file, last reported at $44000.0 in Q1 2026.
- Quarterly Shares Issued fell 96.99% year-over-year to $44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (up 87.01% YoY) and the FY2025 annual result came in at $71000.0, down 13.41% from the prior year.
- Shares Issued climbed to $44000.0 in Q1 2026 per CGTX's latest filing, from $6000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $10.4 million in Q1 2024 and bottomed at -$11.8 million in Q2 2024.
- The 5-year median for Shares Issued is $120500.0 (2023), against an average of $338062.5.
- The widest annual swing landed in 2023, when Shares Issued surged 11282.61%; it then plunged 13894.12% in 2025.
- Tracing CGTX's Shares Issued over 5 years: stood at $23000.0 in 2022, then surged by 11282.61% to $2.6 million in 2023, then sank by 99.35% to $17000.0 in 2024, then sank by 64.71% to $6000.0 in 2025, then surged by 633.33% to $44000.0 in 2026.
- Per Business Quant, the three latest CGTX Shares Issued figures stand at $44000.0 (Q1 2026), $6000.0 (Q4 2025), and -$2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 163.10 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | 44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -2.35 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | 950,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | -11.83 Mn |
| Jun 30, 2024 | -11.83 Mn |
| Mar 31, 2024 | 10.36 Mn |
| Mar 31, 2024 | 10.36 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 197,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | 1.27 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 22,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 303,000.00 |
| Mar 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Dec 31, 2021 | 257,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Mar 31, 2021 | 14,000.00 |